Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cardiovascular Cardiovascular Markers Cell Markers Endothelial Cells

Human CD105 peptide (ab95043)

Price and availability

127 315 ₸

Availability

Order now and get it on Thursday February 25, 2021

Key features and details

  • Suitable for: Blocking

You may also be interested in

Product image
Anti-CD105 antibody (ab74462)
Product image
Recombinant mouse CD105 protein (His tag) (ab276838)
Product image
Human ENG (CD105) knockout HeLa cell line (ab265178)
Product image
Anti-CD146 antibody (ab203118)

Description

  • Product name

    Human CD105 peptide
    See all CD105 proteins and peptides
  • Purity

    70 - 90% by HPLC.

  • Animal free

    No
  • Nature

    Synthetic
    • Species

      Human

Preparation and Storage

  • Alternative names

    • AI528660
    • AI662476
    • CD 105
    • CD105
    • CD105 antigen
    • EGLN_HUMAN
    • END
    • Endoglin
    • Eng
    • FLJ41744
    • HHT1
    • ORW
    • ORW1
    • Osler Rendu Weber syndrome 1
    • RP11 228B15.2
    • S endoglin
    • S-endoglin
    • SN6
    see all
  • Function

    Major glycoprotein of vascular endothelium. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors.
  • Tissue specificity

    Endoglin is restricted to endothelial cells in all tissues except bone marrow.
  • Involvement in disease

    Defects in ENG are the cause of hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300, 108010]; also known as Osler-Rendu-Weber syndrome 1 (ORW1). HHT1 is an autosomal dominant multisystemic vascular dysplasia, characterized by recurrent epistaxis, muco-cutaneous telangiectases, gastro-intestinal hemorrhage, and pulmonary (PAVM), cerebral (CAVM) and hepatic arteriovenous malformations; all secondary manifestations of the underlying vascular dysplasia. Although the first symptom of HHT1 in children is generally nose bleed, there is an important clinical heterogeneity.
  • Cellular localization

    Membrane.
  • Target information above from: UniProt accession P17813 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Human CD105 peptide (ab95043)

  •  
  • Product image

    Recombinant human CD105 protein (ab54338)

    Applications: ELISA, SDS-PAGE, WB

  •  
  • Product image

    Recombinant mouse CD105 protein (ab54339)

    Applications: ELISA, SDS-PAGE

  •  
  • Product image

    Recombinant Mouse CD105 protein (ab222439)

    Applications: SDS-PAGE

  •  
  • Recombinant Human CD105 protein (ab185385)

    Applications: HPLC, SDS-PAGE

Clear all

Recently viewed products

  •  
  • Product image

    Anti-TRBP antibody [EPR13550] (ab180947)

  •  
  • Product image

    Anti-F4/80 antibody [BM8] (ab16911)

  •  
  • Product image

    Anti-PPP1CB antibody [EP1804Y] (ab53315)

  •  
  • Product image

    Anti-Pax2 antibody [EPR8586] (ab150391)

  •  
  • Product image

    Anti-Von Willebrand Factor antibody [EPR12010] (ab179451)

  •  
  • Product image

    Anti-CD3 zeta antibody [EP286Y] (ab40804)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.